Matrix Metalloproteinases and Their Inhibitors After Laser Treatment in Glaucoma
Author Information
Author(s): Mauro Cellini, Pietro Leonetti, Ernesto Strobbe, Emilio C. Campos
Primary Institution: University of Bologna
Hypothesis
The study aims to assess changes in metalloproteinases (MMP-2) and tissue inhibitor of metalloproteinases (TIMP-2) following selective laser trabeculoplasty (SLT) in patients with pseudoexfoliative glaucoma.
Conclusion
The study suggests that IOP elevation after SLT can be a serious adverse event in some PEXG patients, correlated to the failure to decrease the TIMP-2/MMP-2 ratio.
Supporting Evidence
- A significant reduction in IOP was observed in the first 10 days after SLT treatment.
- After a mean time of 31.5 days, IOP increased and returned to pretreatment levels.
- The TIMP-2/MMP-2 ratio was significantly higher in patients with pseudoexfoliative glaucoma compared to controls.
Takeaway
Some patients with a specific type of glaucoma may experience increased eye pressure after laser treatment, which can be linked to changes in certain proteins in their eyes.
Methodology
The study involved 15 patients with pseudoexfoliative glaucoma treated with SLT and compared their MMP-2 and TIMP-2 levels to two control groups.
Potential Biases
Potential selection bias due to the specific inclusion criteria for patients.
Limitations
The study had a small sample size and was limited to specific patient demographics.
Participant Demographics
15 patients with pseudoexfoliative glaucoma (8 males, 7 females, mean age 63.8 years) and 30 control subjects (15 with cataracts and 15 with pseudoexfoliative glaucoma and cataracts).
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website